The Neurointerventional Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for neurointerventional devices has experienced robust expansion in recent years. It is projected to increase from $2.57 billion in 2024 to $2.76 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.5%.
The Neurointerventional Devices Global Market is predicted to expand to a market size of $3.65 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.2%.
Download Your Free Sample of the 2025 Neurointerventional Devices Market Report and Uncover Key Trends Now!The key drivers in the neurointerventional devices market are:
• Rising prevalence of neurological disorders
• Increase in global aging population
• Wide application of neurointerventional devices for minimally invasive treatments
• Enhanced patient outcomes from using these devices
The neurointerventional devices market covered in this report is segmented –
1) By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Device, Flow Diverters Device, Intrasaccular Device, Other Products
2) By Indication: Brain Aneurysm, Stroke, Other Indications
3) By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes
The key trends in the neurointerventional devices market are:
• An increase in development of AI-assisted navigation systems in the neurointerventional devices industry is an upcoming trend.
• The use of advanced technologies for enhancing procedural precision and patient outcomes is an emerging trend.
• There's a focus on reducing intervention time in neurovascular treatments as a trend.
• There is a trend of fostering collaboration through platforms to develop innovative neurovascular solutions.
Major players in the neurointerventional devices market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Stryker Corporation
• Boston Scientific Corporation
• Terumo Corporation
• Kaneka Corporation
• Cook Medical LLC
• Integra LifeSciences Holdings Corporation
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation
• Penumbra Inc.
• Asahi Intecc Co. Ltd.
• MicroVention Inc.
• Phenox GmbH
• Balton Sp. z o.o.
• Zylox-Tonbridge Medical Technology Co. Ltd.
• Balt Group SAS
• Veiva Scientific Co. Ltd.
• InspireMD Inc.
North America was the largest region in the neurointerventional market in 2024